Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Concord Drugs Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE
Add to

33/100
87.44
3.67 (4.38%)

As on 21 Apr, 2026 | 04:01

Day Range
82.00
88.36
L H
52 Week Range
29.00
92.52
L H
Volume
14,453
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
150 86.01 87.50 6284
205 86.00 88.00 757
20 83.03 88.36 50
500 83.01 88.38 100
400 83.00 88.50 2575
0 Total Total 0
Bid / Ask
86.01 / 88.00
Compare Stocks Advanced Chart
NSE
MC Essentials
53% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 0
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          Face Value 0.00
          All Time High 0.00
          All Time Low 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share --
          Dividend Yield --
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Sector PE 0.00

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          33/100
          Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 5.49% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 54.39% in Mar 2026 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          7 out of 12 years Concord Drugs has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 38.32% (2020) 14.53% -12.94% (2018) -5.80% 6.06%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling

          What's your call on  today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          04 Jul, 2025

          Pradeep Kumar Jain

          Qty 69944 Price 54.48 % Traded 0.57
          03 Jul, 2025

          Pradeep Kumar Jain

          Qty 149164 Price 53.21 % Traded 1.13
          03 Jul, 2025

          Ganga Devi Loya

          Qty 51655 Price 53.25 % Traded 0.39
          03 Jul, 2025

          Ganga Devi Loya

          Qty 11555 Price 53.9 % Traded 0.09
          30 Jun, 2025

          Ganga Devi Loya

          Qty 51571 Price 38.66 % Traded 0.37

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          4 Jul, 2025

          pradeep kumar jain

          Qty 69,944 Price 54.48 % Traded 0.00
          3 Jul, 2025

          pradeep kumar jain

          Qty 149,164 Price 53.21 % Traded 0.00
          3 Jul, 2025

          ganga devi loya

          Qty 51,655 Price 53.25 % Traded 0.00
          3 Jul, 2025

          ganga devi loya

          Qty 11,555 Price 53.90 % Traded 0.00
          30 Jun, 2025

          ganga devi loya

          Qty 51,571 Price 38.66 % Traded 0.00
          30 Oct, 2023

          s.nagi reddy

          Qty 171,133 Price 24.75 % Traded 1.84
          30 Oct, 2023

          s.manoj kumar reddy

          Qty 171,133 Price 24.75 % Traded 1.84
          30 Oct, 2023

          s.manoj kumar reddy

          Qty 171,133 Price 24.75 % Traded 1.84
          + Show More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          About the Company

          Concord Drugs Limited was created in 1995 to manufacture and market innovative pharmaceutical products. Concord `s three core product areas are generics, branded and specialty pharmaceuticals. The Company ranks among the top generics suppliers in India. Through an aggressive licensing and acquisition program, Concord is rapidly expanding in branded and specialty pharmaceuticals. With a rigorous focus on growth, Concord develops, manufactures and markets more than 200 prescription and over-the-counter pharmaceutical products
          {"success":1,"data":{"address":{"address1":"Survey No.249,","address2":",","city":"R R District","state":"Telangana","pincode":"501511","telephone1":"040-9052779505","telephone2":"","fax1":"040-","fax2":"","email":"concorddrugsltd@gmail.com","web":"http:\/\/www.concorddrugs.in"},"management":[{"name":"S Nagi Reddy","designation":"Chairman & Managing Director"},{"name":"S Manoj Kumar Reddy","designation":"Whole Time Director"},{"name":"S Koni Reddy","designation":"WholeTime Director & CFO"},{"name":"K Ramachandra Reddy","designation":"Independent Director"},{"name":"Sumeela Kasu","designation":"Independent Director"}],"registrars":{"name":"Aarthi Consultants Pvt Ltd","address1":"1-2-285, Domalguda,","address2":"","address3":"","address4":"","telephone":"040-27638111, 27634445, 27642217, 66611921","fax":"040-27632184","email":"info@aarthiconsultants.com","internet":"http:\/\/www.aarthiconsultants.com","city":"Hyderabad","state":"Telangana","pincode":"500029"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"538965","nseId":"","series":"","isinid":"INE858L01010"}}}

          • Registered Office

          • Registrars

          • Management

            • S Nagi Reddy

              Chairman & Managing Director

            • S Manoj Kumar Reddy

              Whole Time Director

            • S Koni Reddy

              WholeTime Director & CFO

            • K Ramachandra Reddy

              Independent Director

            • Sumeela Kasu

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              538965

            • NSE:

            • Series

            • ISIN

              INE858L01010

          Go to Top

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347